keyword
https://read.qxmd.com/read/38648079/pirin-promotes-the-progression-of-non-small-cell-lung-cancer-by-increasing-odc1-to-suppress-autophagy
#1
JOURNAL ARTICLE
Yan-Ping Li, Zi-Jia Huang, Quan-Kuo He, Yi-Xiang Li, Xiang-Pei Zhao, Zhong-Qi Ma, Mei-Jing Qin, Ai-Wen Chen, Qiu Wei, Yang Wang, Chun-Hua Lu
Non-small-cell lung cancer (NSCLC), a common malignant tumor, requires deeper pathogenesis investigation. Autophagy is an evolutionarily conserved lysosomal degradation process that is frequently blocked during cancer progression. It is an urgent need to determine the novel autophagy-associated regulators in NSCLC. Here, we found that pirin was upregulated in NSCLC, and its expression was positively correlated with poor prognosis. Overexpression of pirin inhibited autophagy and promoted NSCLC proliferation...
April 22, 2024: Journal of Proteome Research
https://read.qxmd.com/read/38647958/selpercatinib-for-treating-recurrent-mixed-medullary-and-follicular-cell-derived-thyroid-carcinoma-a-case-report
#2
JOURNAL ARTICLE
Mei Kadoya, Nobuyasu Suganuma, Yuka Matsubara, Hiroki Takase, Eita Kumagai, Soji Toda, Haruhiko Yamazaki, Katsuhiko Masudo, Satoshi Fujii, Aya Saito
BACKGROUND: Mixed medullary and follicular cell-derived thyroid carcinoma (MMFCC) is characterized by the coexistence of follicular and C cell-derived tumour cell populations within the same lesion. Due to its rarity, its etiology and clinical course remain unclear, and treatment for advanced or recurrent cases has not been established. CASE PRESENTATION: We report a case of MMFCC treated with selpercatinib. The patient was a 69-year-old male presenting with tumors in the right thyroid lobe and in the upper mediastinum...
April 22, 2024: Surgical Case Reports
https://read.qxmd.com/read/38647904/remimazolam-based-total-intravenous-anesthesia-in-a-patient-with-a-confirmed-diagnosis-of-malignant-hyperthermia-a-case-report
#3
JOURNAL ARTICLE
Hiroshi Kondo, Keiko Mukaida, Kurumi Sasai, Yukiko Nao, Ken Hashimoto, Hirotsugu Miyoshi, Rieko Kanzaki, Yasuo M Tsutsumi
BACKGROUND: Malignant hyperthermia (MH) is a rare, life-threatening disorder of calcium homeostasis in skeletal muscle cells that is triggered by volatile anesthetics and succinylcholine, leading to a hypermetabolic reaction. The pathogenic ryanodine receptor 1 (RYR1) gene variant is critical. Patients susceptible to MH should avoid triggering agents, and total intravenous anesthesia (TIVA) is preferred. Remimazolam is safe in patients with suspected MH. CASE PRESENTATION: We present the first case of remimazolam treatment in a genetically confirmed patient with MH without MH development...
April 22, 2024: JA Clinical Reports
https://read.qxmd.com/read/38647670/reasons-why-the-idea-that-radiation-exposures-induce-cancer-needs-to-be-revisited
#4
JOURNAL ARTICLE
Nori Nakamura
PURPOSE: It has long been thought that the carcinogenic effect of radiation resulted from the induction of oncogenic mutations which then led to an increase in the proportion of cancer-bearing individuals. However, even as early as the 1960s, there were indications that the carcinogenic effect of radiation might result from the induction of an earlier onset of cancer. Recently, the former notion was challenged by its inability to explain time-dependent decline of the relative risk following an exposure to radiation, and a parallel shift of mouse survival curves toward younger ages following an exposure to radiation...
April 22, 2024: International Journal of Radiation Biology
https://read.qxmd.com/read/38647604/analysis-of-the-efficacy-of-separation-surgery-for-severe-neurological-compression-in-multiple-myeloma-a-retrospective-analysis-of-35-cases
#5
JOURNAL ARTICLE
Jun-Peng Liu, Xing-Chen Yao, Yue Wu, Zi-Yu Xu, Meng Li, Ming Shi, Jie Ren, Xin-Ru Du
PURPOSE: To investigate the effectiveness and safety of separation surgery for Epidural Spinal Cord Compression (ESCC) graded ≥ 2 in patients with Multiple Myeloma (MM), analyze factors influencing surgical outcomes, and develop a preliminary treatment decision framework for these patients. METHODS: A retrospective analysis was conducted on clinical data from 35 MM patients who underwent separation surgery for ESCC graded ≥ 2 between 2013 and 2018...
April 22, 2024: European Spine Journal
https://read.qxmd.com/read/38647375/y-chromosome-loss-and-implications-for-oncology
#6
JOURNAL ARTICLE
Canan D Dirican, Peter S Nelson
The Y chromosome has recognized functions in promoting male sex determination and regulating aspects of fertility. However, recent work has demonstrated important roles for the Y chromosome and Y-encoded genes in multiple domains of male health, including cancer. It is well-established that males experience shorter life spans than females, and this sex bias on overall mortality is ac-centuated in populations with longer life expectancy, in part related to elevated rates of cancer. The majority of human malignancies exhibit a sex bias with elevated frequencies in males...
April 22, 2024: Molecular Cancer Research: MCR
https://read.qxmd.com/read/38647326/live-imaging-to-quantify-cellular-radiosensitivity-in-patient-derived-tumor-organoids
#7
JOURNAL ARTICLE
Maud Charpentier, Norma Bloy, Silvia C Formenti, Lorenzo Galluzzi, Sandra Demaria
Radiation therapy (RT) is one of the mainstays of modern clinical cancer management. However, not all cancer types are equally sensitive to irradiation, often (but not always) because of differences in the ability of malignant cells to repair oxidative DNA damage as elicited by ionizing rays. Clonogenic assays have been employed for decades to assess the sensitivity of cultured cancer cells to ionizing irradiation, largely because irradiated cancer cells often die in a delayed manner that is difficult to quantify with short-term flow cytometry- or microscopy-assisted techniques...
April 5, 2024: Journal of Visualized Experiments: JoVE
https://read.qxmd.com/read/38647238/uterine-smooth-muscle-tumors-an-overview
#8
JOURNAL ARTICLE
Andre Pinto
Uterine smooth muscle tumors are a heterogeneous group of mesenchymal neoplasms with multiple histologic variants and distinct biological behaviors. Pathologic classification (benign, uncertain malignant potential, malignant) relies on the evaluation of mitotic index, necrosis, and degree of cytologic atypia, with different thresholds based on each subtype. Immunohistochemistry and other ancillary studies may be necessary to establish the diagnosis in a subset of cases, given the morphologic overlap with other mesenchymal neoplasms, including low-grade and high-grade endometrial stromal tumors, inflammatory myofibroblastic tumors, and PEComa...
April 19, 2024: Advances in Anatomic Pathology
https://read.qxmd.com/read/38647036/therapeutic-plasma-exchange-as-an-intervention-for-gemtuzumab-ozogamicin-impaired-hemoglobin-scavenging-a-case-and-systematic-review
#9
Brian D Adkins, Daniel K Noland, Tamra Slone, Arhanti Sadanand
Gemtuzumab ozogamicin (GO) is a CD33 monoclonal antibody-drug conjugate currently in use to treat myeloid malignancies. A unique adverse effect of this medication is destruction of CD33 positive macrophages resulting in reduced clearance of free hemoglobin leading to grossly red plasma. This build-up of free hemoglobin can potentially lead to end organ damage and prevent performance of clinically necessary laboratory evaluation. We present a case of a pediatric patient who developed this adverse effect and was successfully treated with therapeutic plasma exchange (TPE)...
June 2024: Journal of Clinical Apheresis
https://read.qxmd.com/read/38647022/the-interplay-between-crystallinity-and-the-levels-of-zn-and-carbonate-in-synthetic-microcalcifications-directs-thyroid-cell-malignancy
#10
JOURNAL ARTICLE
Lotem Gotnayer Lilian, Yarden Nahmias, Gabriel Yazbek Grobman, Lonia Friedlander, Dina Aranovich, Uri Yoel, Netta Vidavsky
One of the key challenges in diagnosing thyroid cancer lies in the substantial percentage of indeterminate diagnoses of thyroid nodules that have undergone ultrasound-guided fine-needle aspiration (FNA) biopsy for cytological evaluation. This delays the definitive diagnosis and treatment plans. We recently demonstrated that hydroxyapatite microcalcifications (MCs) aspirated from thyroid nodules may aid nodule diagnosis based on their composition. In particular, Zn-enriched MCs have emerged as potential cancer biomarkers...
April 22, 2024: Journal of Materials Chemistry. B, Materials for Biology and Medicine
https://read.qxmd.com/read/38646986/ultrasound-and-cytopathological-characteristics-of-thyroid-tumours-of-uncertain-malignant-potential-from-diagnosis-to-treatment
#11
JOURNAL ARTICLE
Agnieszka Żyłka, Katarzyna Dobruch-Sobczak, Hanna Piotrzkowska-Wróblewska, Maciej Jędrzejczyk, Piotr Góralski, Jacek Gałczyński, Elwira Bakuła-Zalewska, Marek Dedecjus
INTRODUCTION: The latest World Health Organization (WHO) classification from 2022 distinguishes the division of low-risk thyroid neoplasms such as non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP), follicular tumour of uncertain malignant potential (FT-UMP), and well-differentiated tumour of uncertain malignant potential (WDT-UMP). The final diagnosis is made postoperatively according to histopathologic results. The aim of the study was the assessment of ultrasonographic and cytopathological features of borderline lesions to predict low-risk tumours preoperatively and plan the optimal treatment for that group of patients...
April 22, 2024: Endokrynologia Polska
https://read.qxmd.com/read/38646982/standard-therapy-or-additionally-radioactive-iodine-131i-therapy-which-will-stop-the-recurrence-of-glioblastoma-multiforme-gbm
#12
JOURNAL ARTICLE
Agata Czarnywojtek, Paweł Gut, Kamil Dyrka, Jerzy Sowiński, Nadia Sawicka-Gutaj, Katarzyna Katulska, Piotr Stajgis, Mateusz Wykrętowicz, Jakub Moskal, Jeremi Kościński, Krzysztof Pietrończyk, Patryk Graczyk, Maciej Robert Krawczyński, Ewa Florek, Ewelina Szczepanek-Parulska, Marek Ruchała, Alfio Ferlito
Glioblastoma multiforme (GBM) is the most aggressive malignant brain tumour. The average survival time for a patient diagnosed with GBM, using standard treatment methods, is several months. Authors of the article pose a direct question: Is it possible to treat GBM solely with radioactive iodine (¹³¹I) therapy without employing the sodium iodide symporter (NIS) gene? After all, NIS has been detected not only in the thyroid but also in various tumours. The main author of this article (A.C.), with the assistance of her colleagues (physicians and pharmacologists), underwent ¹³¹I therapy after prior iodine inhibition, resulting in approximately 30% reduction in tumour size as revealed by magnetic resonance imaging (MRI)...
April 22, 2024: Endokrynologia Polska
https://read.qxmd.com/read/38646978/retrocarotid-dissection-technique-compared-to-the-caudocranial-approach-for-the-surgical-treatment-of-carotid-body-tumors-a-15-year-experience
#13
JOURNAL ARTICLE
Luis O Bobadilla-Rosado, Javier E Anaya-Ayala, Eros Santos-Chavez, Santiago Mier Y Teran-Ellis, Aliberth Bonilla-Salas, Kenia Rivas-Redonda, Xandra Gomez-Serafin, Hugo Laparra-Escareno, Nina Mendez-Dominguez, Carlos A Hinojosa
INTRODUCTION: Carotid body tumors are rare neoplasms with malignant potential. We aim to follow up on our initial experience published in 2015 and compare the occurrence of complications and postoperative outcomes with the use of retrocarotid dissection (RCD) against the standard caudocranial (SCCD) technique. METHODS: This was an observational, case-control study in which we analyzed all of the carotid body tumor resections performed from 1986 to 2022. Parametric and nonparametric tests were used accordingly...
April 22, 2024: Vascular Medicine
https://read.qxmd.com/read/38646957/metabolite-signature-of-human-malignant-thyroid-tissue-a-systematic-review-and-meta-analysis
#14
REVIEW
S Adeleh Razavi, Babak Khorsand, Pouya Salehipour, Mehdi Hedayati
BACKGROUND: Thyroid cancer (TC) is the predominant malignancy within the endocrine system. However, the standard method for TC diagnosis lacks the capability to identify the pathological condition of all thyroid lesions. The metabolomics approach has the potential to manage this problem by identifying differential metabolites. AIMS: This study conducted a systematic review and meta-analysis of the NMR-based metabolomics studies in order to identify significant altered metabolites associated with TC...
April 2024: Cancer Medicine
https://read.qxmd.com/read/38646934/pyrimidine-depletion-enhances-targeted-and-immune-therapy-combinations-in-acute-myeloid-leukemia
#15
JOURNAL ARTICLE
Ola A Elgamal, Sydney Fobare, Sandip Vibhute, Abeera Mehmood, Dennis C Vroom, Mariah L Johnson, Blaise Stearns, James R Lerma, Jean Truxall, Emily Stahl, Bridget Carmichael, Shelley J Orwick, Alice S Mims, Emily Curran, Ramasamy Santhanam, Susheela Tridandapani, Mitch A Phelps, Zhiliang Xie, Christopher C Coss, Sharyn D Baker, Jeffrey Patrick, Janel K Ezzell, Jayesh Rai, Jianmin Pan, Shesh N Rai, Cody Stillwell, Mark Wunderlich, Mouad Abdulrahim, Thomas E Goodwin, Gerard Hilinski, Chad E Bennett, Erin Hertlein, John C Byrd
Acute myeloid leukemia (AML) is a fatal disease characterized by the accumulation of undifferentiated myeloblasts, and agents that promote differentiation have been effective in this disease but are not curative. Dihydroorotate dehydrogenase inhibitors (DHODHi) have the ability to promote AML differentiation and target aberrant malignant myelopoiesis. We introduce HOSU-53, a DHODHi with significant monotherapy activity, which is further enhanced when combined with other standard-of-care therapeutics. We further discovered that DHODHi modulated surface expression of CD38 and CD47, prompting the evaluation of HOSU-53 combined with anti-CD38 and anti-CD47 therapies, where we identified a compelling curative potential in an aggressive AML model with CD47 targeting...
April 22, 2024: JCI Insight
https://read.qxmd.com/read/38646840/pet-ct-in-leukemia-utility-and-future-directions
#16
JOURNAL ARTICLE
Akram Al-Ibraheem, Sudqi Allouzi, Ahmed Saad Abdlkadir, Miriam Mikhail-Lette, Kamal Al-Rabi, Mohammad Ma'koseh, Peter Knoll, Zaid Abdelrhman, Omar Shahin, Malik E Juweid, Diana Paez, Egesta Lopci
2-Deoxy-2-[18F]fluoro-d-glucose PET/computed tomography ([18F]FDG PET/CT) has proven to be a sensitive method for the detection and evaluation of hematologic malignancies, especially lymphoma. The increasing incidence and mortality rates of leukemia have raised significant concerns. Through the utilization of whole-body imaging, [18F]FDG PET/CT provides a thorough assessment of the entire bone marrow, complementing the limited insights provided by biopsy samples. In this regard, [18F]FDG PET/CT has the ability to assess diverse types of leukemia The utilization of [18F]FDG PET/CT has been found to be effective in evaluating leukemia spread beyond the bone marrow, tracking disease relapse, identifying Richter's transformation, and assessing the inflammatory activity associated with acute graft versus host disease...
April 22, 2024: Nuclear Medicine Communications
https://read.qxmd.com/read/38646799/a-rare-case-of-small-bowel-obstruction-due-to-migration-of-a-percutaneous-biliary-stent
#17
JOURNAL ARTICLE
Luca Ghirardelli, Aldo Alberto Beneduce, Simone Gusmini
Biliary endoprostheses are widely used in the treatment of biliary lithiasis, malignant and benign strictures, and occasionally in long-lasting biliary fistulas. They can be placed endoscopically during endoscopic retrograde cholangiopancreatography and radiologically (percutaneous) when the endoscopic route is not feasible. Complications associated with the endoscopic placement of biliary endoprostheses are well described in the literature, with migration being the most common. Intestinal obstruction is a rare complication associated with the migration of these devices...
2024: Journal of Investigative Medicine High Impact Case Reports
https://read.qxmd.com/read/38646679/a-rare-case-of-a-malignant-epithelioid-neoplasm-with-an-underlying-novel-ewsr1-zbt44-fusion-identified-on-next-generation-sequencing-ngs
#18
JOURNAL ARTICLE
Bharat Rekhi, Akhil Santosh, Sameer Rastogi
The clinicopathological spectrum of undifferentiated round cell sarcomas of bone and soft tissues is expanding after the 5th edition of the WHO classification. A 23-year-old male patient presented with a lump in his left thigh of 3 months' duration. Radiological examination revealed a well-defined, solid-cystic lobulated, soft tissue lesion in the proximal medial region of his left thigh, measuring 7.7 cm in the largest dimension. The referring diagnosis was an epithelioid sarcoma. Histopathological review of the tumor sections revealed a cellular tumor composed of malignant epithelioid to focally "rhabdoid-like" cells in a variable hyalinized and myxoid stroma with geographic areas of necrosis...
April 22, 2024: International Journal of Surgical Pathology
https://read.qxmd.com/read/38646639/il4-receptor-targeting-enables-nab-paclitaxel-to-enhance-reprogramming-of-m2-type-macrophages-into-m1-like-phenotype-via-ros-hmgb1-tlr4-axis-and-inhibition-of-tumor-growth-and-metastasis
#19
JOURNAL ARTICLE
Sri Murugan Poongkavithai Vadevoo, Yeoul Kang, Gowri Rangaswamy Gunassekaran, Seok-Min Lee, Min-Sung Park, Dong Gyun Jo, Sang-Kyun Kim, Ho Lee, Won Jong Kim, Byungheon Lee
Rationale: Nab-paclitaxel (Abx) is widely employed in malignant tumor therapy. In tumor cells and pro-tumoral M2-type macrophages, the IL4 receptor (IL4R) is upregulated. This study aimed to elucidate the selective delivery of Abx to M2-type macrophages by targeting IL4R and reprogramming them into an anti-tumoral M1-type. Methods: Abx was conjugated with the IL4R-binding IL4RPep-1 peptide using click chemistry (IL4R-Abx). Cellular internalization, macrophage reprogramming and signal pathways, and tumor growth and metastasis by IL4R-Abx were examined...
2024: Theranostics
https://read.qxmd.com/read/38646638/hypofractionated-radiotherapy-combined-with-lenalidomide-improves-systemic-antitumor-activity-in-mouse-solid-tumor-models
#20
JOURNAL ARTICLE
Kateryna Onyshchenko, Ren Luo, Xi Rao, Xuanwei Zhang, Simone Gaedicke, Anca-Ligia Grosu, Elke Firat, Gabriele Niedermann
Background: Hypofractionated radiotherapy (hRT) can induce a T cell-mediated abscopal effect on non-irradiated tumor lesions, especially in combination with immune checkpoint blockade (ICB). However, clinically, this effect is still rare, and ICB-mediated adverse events are common. Lenalidomide (lena) is an anti-angiogenic and immunomodulatory drug used in the treatment of hematologic malignancies. We here investigated in solid tumor models whether lena can enhance the abscopal effect in double combination with hRT...
2024: Theranostics
keyword
keyword
18098
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.